REQUEST A DEMO
Total
USD $0.00
Search more companies

Inversiones Rimacar Sas (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Inversiones Rimacar Sas Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Inversiones Rimacar Sas is based in Colombia. The head office is in Bogota D.C.. It operates in the Pharmacies and Drug Stores sector. Inversiones Rimacar Sas was incorporated on July 25, 2022. There are currently 30 (2024) people employed by Inversiones Rimacar Sas. In 2023, the company reported a net sales revenue increase of 493.15%. Its’ total assets recorded a growth of 93.07%. Inversiones Rimacar Sas’s net profit margin increased by 5.72% in 2023.

Headquarters
Cl 163 A # 12 B 32 P 2
Bogota D.C.; Bogota D.C; Postal Code: 1008

Contact Details: Purchase the Inversiones Rimacar Sas report to view the information.

Basic Information
Total Employees:
Purchase the Inversiones Rimacar Sas report to view the information.
Outstanding Shares:
Purchase the Inversiones Rimacar Sas report to view the information.
Incorporation Date:
July 25, 2022
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Subsidiaries
Inversiones Rimacar Sas
Company Performance
Financial values in the chart are available after Inversiones Rimacar Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
493.15%
Total operating revenue
493.15%
Operating profit (EBIT)
116.46%
Net Profit (Loss) for the Period
2748.09%
Total assets
93.07%
Total equity
72.32%
Operating Profit Margin (ROS)
-12.59%
Net Profit Margin
5.72%
Return on Equity (ROE)
43.43%
Quick Ratio
-1.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?